Interesting. At least it confirms that we are not triple checking the same results at 3 independent institutions. Each place is doing a different part of the analysis.
Language seems to have been toned down a little, however still somewhat expectant imo.
Ann: Motor Neurone Disease Phase 1/2 Clinical Trial Update, page-2
-
- There are more pages in this discussion • 164 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.5¢ |
Change
-0.005(2.38%) |
Mkt cap ! $81.16M | |||
| Open | High | Low | Value | Volume |
| 20.5¢ | 21.0¢ | 20.5¢ | $69.63K | 337.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 85711 | 20.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 21.0¢ | 120308 | 6 |
View Market Depth
| Last trade - 13.55pm 26/06/2024 (20 minute delay) ? |
| PAA (ASX) Chart |